Clinical-oncological characteristics and global survival of patients with testicular tumor of germinal cells registered in the central military hospital "CRL Luis Arias Schreiber" in the period from 2004 to 2014

Características clínico-oncológicas y sobrevida global de pacientes con tumor testicular de células germinales registrados en el hospital militar central “CRL Luis Arias Schreiber” en el periodo del 2004 al 2014

  • Robert Malpartida Palomino
  • Rómulo Cárdenas-Agramonte

Abstract

Objective: To identify clinical oncological characteristics and overall survival in patients with seminoma and non-seminoma germ cell testicular tumor.


Methods: Retrospective study in patients with seminoma and non-seminoma germ cell testicular tumors, attended at the Central Military Hospital CRL LUIS ARIAS SCHREIBER, from January 2004 to January 2014. Study variables: tumor markers, stage and treatment. Finally, global survival was realized.


Results: During the study period from January 2004 to January 2014, a total of 26 patients were registered with histopathological diagnosis of germ cell tumor between seminomas and nonseminomas. Histopathologically, the most frequent type was germ cell tumor was non-seminoma type (69.23%), 33% of its variants were mixed tumor type, followed by pure choriocarcinoma with 28%, pure embryonic carcinoma 17% , 11% yolk sac and 11% pure teratoma. Seminoma-type germ cell tumors (30.77%)Within its variants, 62.5% of these were classic seminomas and 37.5% of multinodular seminoma.During the observation period of 179 months with an average of 106 months and a median of 101 months theOverall survival rate at 5 years was 92.3%. (p <0.05).


Conclusion: The present study showed a good prognosis. Survival is attributed substantially to accurate diagnosis and effective treatment. With regard to the management of this neoplasia, testicular tumor of germ cell seminomas and non-seminomas must be multidisciplinary.

 

imagen21.JPG

DOI 10.25176/RFMH.v18.n4.1726

Downloads

Download data is not yet available.
Published
2018-11-27